Clinical Trials

Showing 281 - 300 of 485 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of the MatriStem Surgical Matrix to Reinforce the Esophagus in Patients Having Surgery for Gastric and Esophageal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-178]
Strong, Vivian
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Trametinib with and without GSK2141795 in Patients with Advanced Uveal Melanoma
[Protocol 13-144]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Transoral Surgical Removal of HPV-Positive Locally Advanced Oropharynx Cancer Followed by Risk-Stratified Therapy
Relapsed/Refractory
[Protocol 14-035]
Morris, Luc
  • Head & Neck Cancer
A Phase II Study of Treatment-Free Remission in Chronic-Phase Chronic Myelogenous Leukemia Patients Who Achieve and Sustain a Complete Molecular Response After Switching to Nilotinib
[Protocol 13-152]
Berman, Ellin
  • Leukemia
    • Chronic Myelocytic Leukemia
A Phase II Study of Tremelimumab versus Placebo for Previously Treated Inoperable Mesothelioma
[Protocol 13-092]
Krug, Lee
  • Mesothelioma
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040]
Park, Jae
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122]
Robson, Mark
  • Breast Cancer
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
  • Rare Blood Disorders
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
Relapsed/Refractory
[Protocol 12-200]
Park, Jae
  • Leukemia
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of VS-6063 in Patients with Malignant Pleural Mesothelioma
[Protocol 13-185]
Zauderer, Marjorie
  • Mesothelioma
A Phase II Study of Weekly Paclitaxel with and without LCL161 in Women with Previously Untreated Triple-Negative Breast Cancer
[Protocol 13-082]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Whole Brain Radiation with and without Veliparib in Patients with Brain Metastases from Non-Small Cell Lung Cancer
[Protocol 13-051]
Beal, Kathryn
  • Brain Tumors, Metastatic
  • Lung Cancer, Non-Small Cell
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134]
Krug, Lee
  • Mesothelioma
A Phase II Study to Determine if Patients with Chronic Myelogenous Leukemia Who Respond Well to Nilotinib Can Stop Taking this Drug
[Protocol 13-111]
Berman, Ellin
  • Leukemia
    • Chronic Myelocytic Leukemia
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053]
Krug, Lee
  • Mesothelioma
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143]
Maslak, Peter
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038]
Huang, James
  • Thymoma
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria
  • Kidney Cancer
A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia
[Protocol 08-031]
Boulad, Farid
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Aplastic Anemia
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
  • Pediatric Blood Disorders